Novartis
The role focuses on developing and applying translational physiologically based pharmacokinetic (PBPK) models to support drug discovery, development, and regulatory submissions. The scientist will integrate in vitro and in vivo data to predict drug exposure, assess drug-drug interactions, and support formulation decisions, aiming to optimize clinical trial designs and accelerate patient access to medicines.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Novartis didn’t post a salary, so this is our estimate from similar listings.
15% above the average for this role
Director, Translational Pharmacokinetics - DMPK
Centessa Pharmaceuticals
PBPK Modeler
BioLife Plasma Services
DMPK Scientist
Revolution Medicines
Modelling and Simulation Research Scientist PBPK
Quotient Sciences
Principal Scientist, Drug Metabolism and Pharmacokinetics
alnylam
Sr. Scientist - Translational PBPK Modeling
Genentech